INFUSYSTEM HOLDINGS INC (INFU) Stock Fundamental Analysis
NYSEARCA:INFU - US45685K1025 - Common Stock
10.1 USD
-0.32 (-3.07%)
10.1 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to INFU. INFU was compared to 101 industry peers in the Health Care Providers & Services industry. INFU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. INFU is not valued too expensively and it also shows a decent growth rate. With these ratings, INFU could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
INFU had positive earnings in the past year.
INFU had a positive operating cash flow in the past year.
Each year in the past 5 years INFU has been profitable.
INFU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
INFU's Return On Assets of 5.03% is fine compared to the rest of the industry. INFU outperforms 77.23% of its industry peers.
INFU has a better Return On Equity (9.30%) than 72.28% of its industry peers.
With an excellent Return On Invested Capital value of 9.55%, INFU belongs to the best of the industry, outperforming 80.20% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for INFU is significantly below the industry average of 9.19%.
The last Return On Invested Capital (9.55%) for INFU is above the 3 year average (3.86%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.03% | ||
| ROE | 9.3% | ||
| ROIC | 9.55% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
1.3 Margins
INFU's Profit Margin of 3.63% is fine compared to the rest of the industry. INFU outperforms 69.31% of its industry peers.
INFU's Profit Margin has been stable in the last couple of years.
The Operating Margin of INFU (7.35%) is better than 73.27% of its industry peers.
In the last couple of years the Operating Margin of INFU has grown nicely.
INFU has a better Gross Margin (54.55%) than 77.23% of its industry peers.
INFU's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.35% | ||
| PM (TTM) | 3.63% | ||
| GM | 54.55% |
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), INFU is creating some value.
The number of shares outstanding for INFU has been increased compared to 1 year ago.
Compared to 5 years ago, INFU has more shares outstanding
INFU has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.77 indicates that INFU is not in any danger for bankruptcy at the moment.
INFU has a Altman-Z score of 3.77. This is in the better half of the industry: INFU outperforms 72.28% of its industry peers.
INFU has a debt to FCF ratio of 1.97. This is a very positive value and a sign of high solvency as it would only need 1.97 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.97, INFU belongs to the top of the industry, outperforming 83.17% of the companies in the same industry.
A Debt/Equity ratio of 0.48 indicates that INFU is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.48, INFU is doing good in the industry, outperforming 61.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 1.97 | ||
| Altman-Z | 3.77 |
ROIC/WACC1.11
WACC8.64%
2.3 Liquidity
A Current Ratio of 2.19 indicates that INFU has no problem at all paying its short term obligations.
INFU's Current ratio of 2.19 is fine compared to the rest of the industry. INFU outperforms 77.23% of its industry peers.
INFU has a Quick Ratio of 1.84. This is a normal value and indicates that INFU is financially healthy and should not expect problems in meeting its short term obligations.
INFU's Quick ratio of 1.84 is fine compared to the rest of the industry. INFU outperforms 70.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 1.84 |
3. Growth
3.1 Past
INFU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1816.67%, which is quite impressive.
The Earnings Per Share has been growing by 10.59% on average over the past years. This is quite good.
Looking at the last year, INFU shows a quite strong growth in Revenue. The Revenue has grown by 8.13% in the last year.
INFU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.70% yearly.
EPS 1Y (TTM)1816.67%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%300%
Revenue 1Y (TTM)8.13%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%6.84%
3.2 Future
Based on estimates for the next years, INFU will show a very strong growth in Earnings Per Share. The EPS will grow by 71.90% on average per year.
Based on estimates for the next years, INFU will show a small growth in Revenue. The Revenue will grow by 7.77% on average per year.
EPS Next Y160.1%
EPS Next 2Y97.91%
EPS Next 3Y71.9%
EPS Next 5YN/A
Revenue Next Year6.09%
Revenue Next 2Y6.32%
Revenue Next 3Y7.77%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 43.91, the valuation of INFU can be described as expensive.
INFU's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.03. INFU is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 25.79, which means the current valuation is very expensive for INFU.
INFU's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.54. INFU is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.91 | ||
| Fwd PE | 25.79 |
4.2 Price Multiples
INFU's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. INFU is cheaper than 71.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, INFU is valued a bit cheaper than the industry average as 75.25% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.42 | ||
| EV/EBITDA | 9.87 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INFU has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as INFU's earnings are expected to grow with 71.90% in the coming years.
PEG (NY)0.27
PEG (5Y)4.15
EPS Next 2Y97.91%
EPS Next 3Y71.9%
5. Dividend
5.1 Amount
INFU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.1
-0.32 (-3.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners78.54%
Inst Owner Change-3.29%
Ins Owners4.42%
Ins Owner Change0.56%
Market Cap206.34M
Analysts83.64
Price Target12.75 (26.24%)
Short Float %0.85%
Short Ratio0.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.14%
Min EPS beat(2)75.49%
Max EPS beat(2)226.8%
EPS beat(4)3
Avg EPS beat(4)69.56%
Min EPS beat(4)-48.06%
Max EPS beat(4)226.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)0.99%
Revenue beat(4)2
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)0.99%
Revenue beat(8)4
Avg Revenue beat(8)-0.36%
Revenue beat(12)6
Avg Revenue beat(12)-0.46%
Revenue beat(16)7
Avg Revenue beat(16)-1.59%
PT rev (1m)-6.02%
PT rev (3m)-8.26%
EPS NQ rev (1m)42.86%
EPS NQ rev (3m)4.81%
EPS NY rev (1m)44.34%
EPS NY rev (3m)44.34%
Revenue NQ rev (1m)-2.76%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-1.8%
Revenue NY rev (3m)-1.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.91 | ||
| Fwd PE | 25.79 | ||
| P/S | 1.48 | ||
| P/FCF | 15.42 | ||
| P/OCF | 7.77 | ||
| P/B | 3.78 | ||
| P/tB | 4.72 | ||
| EV/EBITDA | 9.87 |
EPS(TTM)0.23
EY2.28%
EPS(NY)0.39
Fwd EY3.88%
FCF(TTM)0.66
FCFY6.49%
OCF(TTM)1.3
OCFY12.87%
SpS6.85
BVpS2.67
TBVpS2.14
PEG (NY)0.27
PEG (5Y)4.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.03% | ||
| ROE | 9.3% | ||
| ROCE | 12.09% | ||
| ROIC | 9.55% | ||
| ROICexc | 9.63% | ||
| ROICexgc | 11.06% | ||
| OM | 7.35% | ||
| PM (TTM) | 3.63% | ||
| GM | 54.55% | ||
| FCFM | 9.57% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
ROICexc(3y)3.88%
ROICexc(5y)5.02%
ROICexgc(3y)4.43%
ROICexgc(5y)5.92%
ROCE(3y)4.88%
ROCE(5y)5.98%
ROICexcg growth 3Y31.39%
ROICexcg growth 5Y0.4%
ROICexc growth 3Y34.21%
ROICexc growth 5Y4.6%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
F-Score9
Asset Turnover1.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 1.97 | ||
| Debt/EBITDA | 1.12 | ||
| Cap/Depr | 99.64% | ||
| Cap/Sales | 9.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 113.02% | ||
| Profit Quality | 263.84% | ||
| Current Ratio | 2.19 | ||
| Quick Ratio | 1.84 | ||
| Altman-Z | 3.77 |
F-Score9
WACC8.64%
ROIC/WACC1.11
Cap/Depr(3y)114.8%
Cap/Depr(5y)115.78%
Cap/Sales(3y)11.93%
Cap/Sales(5y)13.88%
Profit Quality(3y)4561.75%
Profit Quality(5y)2764.31%
High Growth Momentum
Growth
EPS 1Y (TTM)1816.67%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%300%
EPS Next Y160.1%
EPS Next 2Y97.91%
EPS Next 3Y71.9%
EPS Next 5YN/A
Revenue 1Y (TTM)8.13%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%6.84%
Revenue Next Year6.09%
Revenue Next 2Y6.32%
Revenue Next 3Y7.77%
Revenue Next 5YN/A
EBIT growth 1Y159.69%
EBIT growth 3Y34.69%
EBIT growth 5Y14.35%
EBIT Next Year297.98%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y355.58%
FCF growth 3Y16.52%
FCF growth 5YN/A
OCF growth 1Y157.31%
OCF growth 3Y3.76%
OCF growth 5Y8.08%